Table 2 Demographics, comorbidities and antithrombotic medication use (N = 789)
Characteristic | n (%) |
|---|---|
Demographics | |
Median age (interquartile range) in years | 77 (66–84) |
Male sex | 445 (56.4) |
Comorbidities | |
Diabetes | 276 (35.0) |
Hypertension | 414 (52.5) |
Cancer | |
No intracranial involvement | 123 (15.6) |
Intracranial involvement | 19 (2.4) |
eGFR< 30 ml/min/1.73m2 | 83 (10.5) |
Liver cirrhosis | 43 (5.8) |
Coagulopathy INR ≥ 1.5 | 31 (3.9) |
Platelet count < 50,000/μL | 15 (1.9) |
Cognitive impairment | |
Dementia | 144 (18.3) |
Intellectual disability or ABI | 27 (3.4) |
Delirium | 201 (25.4) |
Obesitya | 158 (25.7) |
Median BMI (interquartile range) in kg/m2 | 25.6 (21.5–30.4) |
Medications affecting coagulation | |
Single antiplatelet | 245 (31.1) |
Dual antiplatelet | 51 (6.5) |
Anticoagulants | |
Warfarin | 65 (8.2) |
Novel oral anticoagulantsb | 67 (8.5) |
Heparin (therapeutic dosage) | 35 (4.4) |
Non-steroidal anti-inflammatories | 22 (2.8) |